Ophthalmic Drug Delivery Summit to Convene in San Francisco

In January, over 60 world-leading specialists in ophthalmic drug delivery will gather in San Francisco for the 3rd annual Ophthalmic Drug Delivery Summit, an industry-focused event dedicated to enhancing the effectiveness, durability, and minimally invasive nature of retinal drug delivery.

The 3-day event covers topics such as suprachoroidal drug delivery, gene therapy transduction, sustained-release formulations, and release kinetics. Attendees will have the opportunity to explore strategies and clinical applications of these emerging technologies in retinal and ocular care.

Experts from organizations including Genentech, AbbVie, Bayer, Clearside Biomedical, Ocular Therapeutix, Regenxbio, Regeneron, and Eyepoint Pharmaceuticals are slated to present at the event. The conference offers an opportunity to discuss new findings, exchange insights, and investigate the latest advances in ophthalmic drug delivery technologies.

Kicking off the summit, the pre-conference workshop will feature presentations by Everads Therapy and Aviceda, with sessions designed to deepen participants' understanding of suprachoroidal delivery in gene therapy and address challenges in ophthalmic clinical trial design. Data readouts from industry players such as Genentech, Alcon, GelMEDIX, and Ray Therapeutics will also be presented during the main conference days. Beyond the scientific content, the summit has been designed to promote meaningful networking opportunities. 

For more information and to view the full agenda, visit: https://ter.li/k969po.